Home › Heart Failure › Texas
Heart Failure clinical trials in Texas
68 studies for Heart Failure are looking for participants at sites in Texas.
Cities in Texas
- Dallas43 studies
- Houston36 studies
- Austin18 studies
- Plano11 studies
- Amarillo8 studies
- Tyler8 studies
- The Woodlands7 studies
- El Paso7 studies
- Fort Worth7 studies
- McKinney7 studies
- Killeen7 studies
- San Antonio6 studies
- Waco4 studies
- Grand Prairie4 studies
- Denison4 studies
- McAllen3 studies
- Cypress3 studies
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
- University of Texas Southwestern Medical Center, Dallas
- Parkland Health & Hospital System (PHHS), Dallas
- Baylor Scott and White - Health System, Dallas
Recruiting
All ages · All sexes · Updated Sep 29, 2026 · NCT06593327BiVACOR® Total Artificial Heart Early Feasibility Study
- Texas Heart Institute / Baylor St. Luke's Medical Center, Houston
Recruiting
Ages 18 to 70 · All sexes · Updated Sep 28, 2026 · NCT06174103A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Dallas
- Research Site, DeSoto
- Research Site, El Paso
- and 8 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Baylor University Medical Center, Dallas
- The University of Texas Southwestern Medical Center, Dallas
- University of Texas Medical Branch - UTMB, Galveston
- and 2 more
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 24, 2026 · NCT06736574Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
- CHRISTUS Trinity Mother Frances, Tyler
Recruiting
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07232030Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
- University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location, Dallas
Recruiting
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07222813A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Pharmatex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Incorporated, Amarillo
- NextStage Clinical Research, Beaumont
- and 14 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06935370A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Pharmatex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Incorporated, Amarillo
- Texas Health Research and Education Institute, Dallas
- and 8 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06424288A Study of LY3971297 in Participants With Heart Failure
- Houston Methodist Hospital, Houston
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Sep 22, 2026 · NCT07547540Alleviant ALLAY-HFrEF Study
- Hendrick Health, Abilene
- Austin Heart, Austin
- Baylor Scott & White Research Institute, Plano
- and 2 more
Recruiting
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06812533Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- PharmaTex Research, LLC, Amarillo
- Austin Heart, Austin
- Javara Research, Conroe
- and 13 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 16, 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Austin
- Research Site, Beaumont
- Research Site, Brownsville
- and 17 more
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 15, 2026 · NCT06677060Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Allen
- Research Site, Amarillo
- Research Site, Amarillo
- and 13 more
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 11, 2026 · NCT06307652Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
- Methodist DeBakey Heart and Vascular Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07436299A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Amarillo, TX Investigative Site 10045, Amarillo
- Austin, TX Investigative Site 10015, Austin
- Dallas, TX Investigative Site 10042, Dallas
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06008197A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10045 Amarillo, TX Investigational Site, Amarillo
- CON-10015 Austin, TX Investigational Site, Austin
- CON-10304, Denison, TX, Denison
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06024746The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
- Texas Cardiac Arrhythmia Research Foundation, Austin
RecruitingObservational study
Ages 22 and older · All sexes · Updated Sep 10, 2026 · NCT07098858Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Baylor University Medical Center, part of Baylor Scott & White Health, Dallas
- UT southwestern Medical Center, Dallas
- Houston Methodist Hospital, Houston
- and 3 more
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Heart Hospital Baylor Plano, Plano
- Christus Trinity Mother Frances Health System, Tyler
Recruiting
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07069738A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 167, Dallas
- Local Institution - 151, Houston
- Local Institution - 157, Houston
- and 1 more
RecruitingPhase 2
Ages 30 to 84 · All sexes · Updated Aug 31, 2026 · NCT07795814Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Children's Health-The Heart Center ( Site 0015), Dallas
- Texas Children's Hospital ( Site 0039), Houston
RecruitingPhase 2/3
29 Days – 17 Years · All sexes · Updated Aug 28, 2026 · NCT05714085AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- University of Texas Southwestern Medical Center, Dallas, Dallas
- Center for Advanced Heart Failure, Houston
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Aug 27, 2026 · NCT06793371Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Texas Heart Institute, Houston
Recruiting
Ages 21 and older · All sexes · Updated Aug 25, 2026 · NCT05677100Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
- Texas Children's Hospital, Houston
RecruitingObservational study
Up to age 18 · All sexes · Updated Aug 25, 2026 · NCT06532890Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Dell Children's Medical Center of Central Texas, Austin
RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Austin
- Dallas
- Fort Worth
- and 3 more
RecruitingObservational study
All ages · All sexes · Updated Aug 20, 2026 · NCT00271180LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Austin
- Tenax Investigational Site, Dallas
- Tenax Investigational Site, El Paso
- and 1 more
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Aug 19, 2026 · NCT07288398A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- North Texas Cardiology Center, Dallas
- Baylor Scott & White Research Institute, Dallas
- The Methodist Hospital, Methodist Cancer Cencer, Houston
- and 3 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- PharmaTex Research, LLC, Amarillo
- Austin Heart, Austin
- Javara Inc. / Privia Medical Group Gulf Coast PLLC, Conroe
- and 24 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001Alleviant ALLAY-HF Study
- Hendrick Health, Abilene
- Austin Heart, Austin
- UT Southwestern, Dallas
- and 2 more
Recruiting
Ages 40 and older · All sexes · Updated Aug 14, 2026 · NCT05685303CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Recruiting
Ages 60 and older · All sexes · Updated Aug 14, 2026 · NCT05996328OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
- Baylor University Medical Center, Dallas
RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Aug 11, 2026 · NCT06939751Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Children's Health Dallas, Dallas
RecruitingPhase 2
Ages 0 to 16 · All sexes · Updated Aug 10, 2026 · NCT06080074Assessment of CCM in HF With Higher Ejection Fraction
- Ascension Seton, Austin
- Austin Heart, Austin
- Baylor Scott and White Research Institute, Dallas
- and 7 more
Recruiting
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT05064709A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Amarillo Medical Specialists, Amarillo
- University of Texas Southwestern Medical Center, Dallas
- Texama Medical Center, Denison
- and 1 more
RecruitingPhase 2
Ages 40 to 84 · All sexes · Updated Aug 5, 2026 · NCT06979362ELEVATE-HFpEF Clinical Study
- Dallas VA Medical Center, Dallas
- Texas Health Research & Education Institute, Fort Worth
Recruiting
Ages 40 and older · All sexes · Updated Aug 3, 2026 · NCT06678841A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10015 Austin, TX Investigational Site, Austin
- FIN-10404, Denison, TX, Denison
- FIN-10085, Houston, TX, Houston
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT0603395018F-mFBG Imaging for Myocardial Sympathetic Innervation
- UT Health Houston, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT06965621PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Austin Heart, Austin
- Medical City Healthcare Dallas, Dallas
- Baylor Scott & White -Dallas, Dallas
- and 3 more
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Medical Center Dallas - Cardiology, Dallas
- Texas Children's Hospital - Cardiology, Houston
RecruitingPhase 3
Up to age 18 · All sexes · Updated Jun 29, 2026 · NCT07192952From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.